Literature DB >> 3215513

Alternative splicing of tropomyosin pre-mRNAs in vitro and in vivo.

D M Helfman1, W M Ricci, L A Finn.   

Abstract

A single rat gene encodes both fibroblast TM-1 and skeletal muscle beta-tropomyosin by an alternative RNA-processing mechanism. The gene contains 11 exons: Exons 1-5 and exons 8 and 9 are constitutive exons common to all mRNAs expressed from this gene; exons 6 and 11 are used in fibroblasts as well as smooth muscle; exons 7 and 10 are used exclusively in skeletal muscle. We have studied the internal alternative RNA splice choice (exons 6 and 7) of the rat tropomyosin 1 gene in vitro, using nuclear extracts obtained from HeLa cells. Use of alternative splice sites in vitro is dependent on the ionic conditions of the assay, and correct splicing occurs only under well-defined salt conditions. Splicing of exon 5 to exon 6 (fibroblast-type splice) and exon 5 to exon 7 (skeletal muscle-type splice) was dependent on precursors in which exon 6 or 7 was first joined to exon 8. The same patterns of alternatively spliced RNAs were formed when similar templates were introduced in HeLa cells by transfection. Thus, there appears to be an ordered pathway of splicing in which the internal alternatively spliced exons must first be joined to the downstream constitutive exon before they can be spliced to the upstream constitutive exon. The data are consistent with a model in which the critical event in alternative splicing occurs during the joining of exon 6 to exon 8 (fibroblast-type splice) or exon 7 to exon 8 (skeletal muscle-type splice).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215513     DOI: 10.1101/gad.2.12a.1627

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  43 in total

1.  cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene.

Authors:  M E Gallego; L Balvay; E Brody
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Regulated adenovirus mRNA 3'-end formation in a coupled in vitro transcription-processing system.

Authors:  S I Wilson-Gunn; J E Kilpatrick; M J Imperiale
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Multiple activities of the human splicing factor ASF.

Authors:  J E Harper; J L Manley
Journal:  Gene Expr       Date:  1992

4.  Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences.

Authors:  I R Graham; M Hamshere; I C Eperon
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

5.  Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP.

Authors:  G J Cote; D T Stolow; S Peleg; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

6.  Rapid, diffusional shuttling of poly(A) RNA between nuclear speckles and the nucleoplasm.

Authors:  Joan C Ritland Politz; Richard A Tuft; Kannanganattu V Prasanth; Nina Baudendistel; Kevin E Fogarty; Larry M Lifshitz; Jörg Langowski; David L Spector; Thoru Pederson
Journal:  Mol Biol Cell       Date:  2005-12-21       Impact factor: 4.138

7.  A novel protein factor is required for use of distal alternative 5' splice sites in vitro.

Authors:  J E Harper; J L Manley
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

8.  cis-acting elements and a trans-acting factor affecting alternative splicing of adenovirus L1 transcripts.

Authors:  C Delsert; N Morin; D F Klessig
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points.

Authors:  J S Grossman; M I Meyer; Y C Wang; G J Mulligan; R Kobayashi; D M Helfman
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

10.  Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.

Authors:  B A Amendt; D Hesslein; L J Chang; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.